Royal Bank of Canada
QNTM

Royal Bank of Canada’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Royal Bank of Canada’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
19
-36
-65% -$162 ﹤0.01% 7821
2025
Q4 		$0 Sell
55
-528
-91% -$5.76K ﹤0.01% 7763
2025
Q3 		$10K Buy
583
+501
+611% +$9.89K ﹤0.01% 6502
2025
Q2 		$2K Buy
82
+63
+332% +$777 ﹤0.01% 6835
2025
Q1 		$0 Sell
19
-360
-95% -$2.07K ﹤0.01% 7321
2024
Q4 		$1K Buy
379
+272
+254% +$1.28K ﹤0.01% 6826
2024
Q3 		$0 Buy
107
+86
+410% +$536 ﹤0.01% 7583
2024
Q2 		$0 Sell
21
-72
-77% -$1.76K ﹤0.01% 7632
2024
Q1 		$4K Buy
93
+55
+145% +$3.01K ﹤0.01% 6545
2023
Q4 		$2K Buy
38
+24
+171% +$1.69K ﹤0.01% 6856
2023
Q3 		$1K Sell
14
-19
-58% -$1.55K ﹤0.01% 6966
2023
Q2 		$2K Buy
33
+5
+18% +$429 ﹤0.01% 6917
2023
Q1 		$3K Sell
28
-12
-30% -$1.03K ﹤0.01% 6720
2022
Q4 		$2K Buy
40
+2
+5% +$111 ﹤0.01% 6959
2022
Q3 		$2K Sell
38
-15
-28% -$881 ﹤0.01% 7082
2022
Q2 		$3K Buy
53
+17
+47% +$1.02K ﹤0.01% 6871
2022
Q1 		$3K Buy
36
+25
+227% +$1.51K ﹤0.01% 7415
2021
Q4 		$1K Sell
11
-3
-21% -$260 ﹤0.01% 7554
2021
Q3 		$1K Hold
14
– – ﹤0.01% 7518
2021
Q2 		$1K Buy
14
+9
+180% +$1.04K ﹤0.01% 7357
2021
Q1 		$1K Sell
5
-10
-67% -$1.4K ﹤0.01% 7333
2020
Q4 		$1K Sell
15
-3
-17% -$354 ﹤0.01% 6981
2020
Q3 		$3K Sell
18
-18
-50% -$3.74K ﹤0.01% 6269
2020
Q2 		$9K Buy
36
+25
+227% +$5.86K ﹤0.01% 5877
2020
Q1 		$2K Buy
+11
New +$3.64K ﹤0.01% 6347

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Royal Bank of Canada's QNTM Position: Q1 2026 in Review

Royal Bank of Canada reduced its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) stake by 65% in Q1 2026, selling an estimated $162 and leaving 19 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7821.

Royal Bank of Canada first reported a position in QNTM in Q1 2020 and has held it in 25 quarters since. The position peaked at $10K in Q3 2025. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

  • Royal Bank of Canada held 19 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $0 as of Q1 2026.
  • Royal Bank of Canada sold 36 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2026, an estimated $162.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7821 holding.
  • Royal Bank of Canada first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2020 and has held it in 25 quarters since.
  • Royal Bank of Canada's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $10K in Q3 2025.
  • 25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.